Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lister

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Blood|October 20, 2005
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AMLDaniel J Pearce, David Taussig, Kazem Zibara, et al.
British Journal of Haematology|January 6, 2009
BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocationsNoraidah Masir, Lisa J Campbell, Lindsey K Goff, et al.
Blood|February 10, 2009
Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma cloneEmanuela Carlotti, David Wrench, Janet Matthews, et al.
British Journal of Haematology|October 1, 2010
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemiaAgathoclis Agathocleous, Ama Rohatiner, Simon Rule, et al.
British Journal of Haematology|July 26, 2002
JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangementsMichael J Jenner, Karin E Summers, Andrew J Norton, et al.
British Journal of Haematology|March 28, 2012
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignanciesRebecca L Auer, Finlay MacDougall, Heather E Oakervee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-upAma Z S Rohatiner, Lee Nadler, Andrew J Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of CalreticulinDaniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
Seminars in Oncology|April 30, 2003
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRobert A Kyle, Steven P Treon, Raymond Alexanian, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 11, 2003
Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemiaChristopher D Dalley, Michael J Neat, Nicola J Foot, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Blood|October 20, 2005
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AMLDaniel J Pearce, David Taussig, Kazem Zibara, et al.
British Journal of Haematology|January 6, 2009
BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocationsNoraidah Masir, Lisa J Campbell, Lindsey K Goff, et al.
Blood|February 10, 2009
Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma cloneEmanuela Carlotti, David Wrench, Janet Matthews, et al.
British Journal of Haematology|October 1, 2010
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemiaAgathoclis Agathocleous, Ama Rohatiner, Simon Rule, et al.
British Journal of Haematology|July 26, 2002
JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangementsMichael J Jenner, Karin E Summers, Andrew J Norton, et al.
British Journal of Haematology|March 28, 2012
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignanciesRebecca L Auer, Finlay MacDougall, Heather E Oakervee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-upAma Z S Rohatiner, Lee Nadler, Andrew J Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of CalreticulinDaniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
Seminars in Oncology|April 30, 2003
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRobert A Kyle, Steven P Treon, Raymond Alexanian, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 11, 2003
Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemiaChristopher D Dalley, Michael J Neat, Nicola J Foot, et al.
Pageof 12